{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:50:40Z","timestamp":1788263440144,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04172-x","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:31:12Z","timestamp":1756823472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiple sclerosis patients\u2019 journey delay in diagnosis and treatment: a multicenter study"],"prefix":"10.1186","volume":"25","author":[{"given":"Salma","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem Hamdy","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah-Almamun","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Mohamed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Embaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Ali","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"4172_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Prim. 2018;4:43.","journal-title":"Nat Rev Dis Prim"},{"key":"4172_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"E Leray","year":"2016","unstructured":"Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol. 2016;172:3\u201313.","journal-title":"Rev Neurol"},{"key":"4172_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373.","journal-title":"Lancet Neurol"},{"key":"4172_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00415-010-5560-1","volume":"257","author":"O Fernandez","year":"2010","unstructured":"Fernandez O, Fernandez V, Arbizu T, Izquierdo G, Bosca I, Arroyo R, et al. Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study). J Neurol. 2010;257:1500\u20137.","journal-title":"J Neurol"},{"key":"4172_CR5","first-page":"S4","volume":"10","author":"JR Miller","year":"2004","unstructured":"Miller JR. The importance of early diagnosis of multiple sclerosis. J Manag Care Pharm. 2004;10:S4\u201311.","journal-title":"J Manag Care Pharm"},{"key":"4172_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jama.2012.8327","volume":"308","author":"T Derfuss","year":"2012","unstructured":"Derfuss T, Kappos L. Evaluating the potential benefit of interferon treatment in multiple sclerosis. JAMA. 2012;308:290\u20131.","journal-title":"JAMA"},{"key":"4172_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.24747","volume":"80","author":"MS-EPIC Team","year":"2016","unstructured":"University of California - San Francisco, Team MS-EPIC, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016;80:499\u2013510.","journal-title":"Ann Neurol"},{"key":"4172_CR8","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1212\/WNL.0000000000003078","volume":"87","author":"L Kappos","year":"2016","unstructured":"Kappos L, Edan G, Freedman MS, Montalban X, Hartung HP, Hemmer B, et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology. 2016;87:978\u201387.","journal-title":"Neurology"},{"key":"4172_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2010.02.007","volume":"292","author":"E Kingwell","year":"2010","unstructured":"Kingwell E, Leung AL, Roger E, Duquette P, Rieckmann P, Tremlett H, et al. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts. J Neurol Sci. 2010;292:57\u201362.","journal-title":"J Neurol Sci"},{"issue":"1","key":"4172_CR10","first-page":"26","volume":"92","author":"J Andrew","year":"2019","unstructured":"Andrew J, Solomon RT, Naismith, Anne H. Misdiagnosis of multiple sclerosis impact of the 2017 McDonald criteria on clinical practice. Cross Neurol Jan. 2019;92(1):26\u201333.","journal-title":"Cross Neurol Jan"},{"key":"4172_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11910-013-0403-y","volume":"13","author":"AJ Solomon","year":"2013","unstructured":"Solomon AJ, Weinshenker BG. Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep. 2013;13:403.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4172_CR12","doi-asserted-by":"crossref","unstructured":"Albanese M, sara zagaglia et al. 2016. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. J Neuroinflammation. 2016; 13: 36.","DOI":"10.1186\/s12974-016-0502-1"},{"key":"4172_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","journal-title":"Neurology"},{"issue":"7","key":"4172_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","volume":"64","author":"RH Roxburgh","year":"2005","unstructured":"Roxburgh RH, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology. 2005;64(7):1144\u201351.","journal-title":"Neurology"},{"key":"4172_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clineuro.2024.108221","volume":"239","author":"F Khodaie","year":"2024","unstructured":"Khodaie F, Moghadasi AN, Hosseinnataj A, et al. Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A National registry-based study. Clin Neurol Neurosurg. 2024;239:108\u2013221.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"4172_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13760-020-01528-7","volume":"121","author":"M Ghiasian","year":"2021","unstructured":"Ghiasian M, Faryadras M, Mansour M, Khanlarzadeh E, Mazaheri S. Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990\u20132016. Acta Neurol Belg. 2021;121(1):199\u2013204.","journal-title":"Acta Neurol Belg"},{"issue":"16","key":"4172_CR17","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","volume":"89","author":"A Thormann","year":"2017","unstructured":"Thormann A, Sorensen PS, KochHenriksen N, Laursen B, Magyari M. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Neurology. 2017;89(16):1668.","journal-title":"Neurology"},{"key":"4172_CR18","first-page":"170","volume":"7","author":"Y Bahou","year":"2023","unstructured":"Bahou Y, Al Ma\u2019ani MY, Mahmoud LJ, Balkar YS, Dwaik HA, et al. Multiple sclerosis awareness in Jordan, and how does it affect the time of diagnosis. J Hosp Health Care Admin. 2023;7:170.","journal-title":"J Hosp Health Care Admin"},{"issue":"4","key":"4172_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.20344\/amp.11187","volume":"32","author":"A Aires","year":"2019","unstructured":"Aires A, et al. Diagnostic delay of multiple sclerosis in a Portuguese population. Acta Med Port. 2019;32(4):289\u201394.","journal-title":"Acta Med Port"},{"key":"4172_CR20","doi-asserted-by":"publisher","first-page":"106278","DOI":"10.1016\/j.clineuro.2020.106278","volume":"199","author":"F Mobasheri","year":"2020","unstructured":"Mobasheri F, Jaberi AR, Hasanzadeh J, Fararouei M. Multiple sclerosis diagnosis delay and its associated factors among Iranian patients. Clin Neurol Neurosurg. 2020;199:106278.","journal-title":"Clin Neurol Neurosurg"},{"key":"4172_CR21","doi-asserted-by":"crossref","unstructured":"Khedr EM, El Malky I, Hussein HB et al. Multiple sclerosis diagnostic delay and its associated factors in upper Egyptian patients. Sci Rep.3023; 13, 2249.","DOI":"10.1038\/s41598-023-28864-x"},{"key":"4172_CR22","unstructured":"Multiple sclerosis in. adults: management. Clinical guideline [CG186]. October 2014. [accessed 2017 Apr 11]. Available from: https:\/\/www.nice.org.uk\/guidance\/cg186"},{"issue":"6","key":"4172_CR23","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1212\/WNL.0000000000207481","volume":"101","author":"AJ Solomon","year":"2023","unstructured":"Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L, Bae E, Shinohara R. King R, Laurson-Doube J and Helme A. Global barriers to the diagnosis of multiple sclerosis. Neurology. 2023;101(6):e624\u201335.","journal-title":"Neurology"},{"key":"4172_CR24","doi-asserted-by":"crossref","unstructured":"Tohamy AA, Swelam MS, Abdelgawad DM, Aref HA. Causes of delayed diagnosis of multiple sclerosis in Egypt. QJM Int J Med. 2020;113.","DOI":"10.1093\/qjmed\/hcaa054.011"},{"issue":"7","key":"4172_CR25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/01.wnl.0000178891.20579.64","volume":"65","author":"RA Marrie","year":"2005","unstructured":"Marrie RA, et al. Changes in the ascertainment of multiple sclerosis. Neurology. 2005;65(7):1066\u201370.","journal-title":"Neurology"},{"key":"4172_CR26","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Robledo S, Lopez-Reyes L, Arenas-Vargas LE, Carvajal-Parra MS, Gu\u00edo-S\u00e1nchez C. Delayed diagnosis of multiple sclerosis in a low prevalence country. Neurol Res 2021 43(7), 521\u20137.","DOI":"10.1080\/01616412.2020.1866374"},{"key":"4172_CR27","doi-asserted-by":"crossref","unstructured":"Patti F, Chisari CG, Arena S, Toscano S, Finocchiaro C. Salvatore Lo Fermo, Maria Luisa Judica, Davide Maimone, Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study, Multiple Sclerosis and Related Disorders.2022; Volume 57.","DOI":"10.1016\/j.msard.2021.103361"},{"key":"4172_CR28","first-page":"100","volume":"87","author":"N Grytten","year":"2016","unstructured":"Grytten N, Aarseth JH, Lunde HMB. AlA 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County. Western NorwayJournal Neurol Neurosurg Psychiatry. 2016;87:100\u20135.","journal-title":"Western NorwayJournal Neurol Neurosurg Psychiatry"},{"key":"4172_CR29","first-page":"65","volume":"22","author":"A Hosseinnataj","year":"2023","unstructured":"Hosseinnataj A, Nikbakht R, Mousavinasab SN, Eskandarieh S, Sahraian MA, Baghbanian SM. Factors associated with the number of months of delaying in multiple sclerosis diagnosis: comparison of count regression models. Curr J Neurol. 2023;22:65\u201371.","journal-title":"Curr J Neurol"},{"issue":"3","key":"4172_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5588\/ijtld.17.0539","volume":"22","author":"LG Ngwira","year":"2018","unstructured":"Ngwira LG, Dowdy DW, Khundi M, et al. Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi. Int J Tuberc Lung Dis. 2018;22(3):280\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"4172_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40615-015-0132-9","volume":"3","author":"F Williams","year":"2016","unstructured":"Williams F, Thompson. E.Disparity in breast cancer late stage at diagnosis in Missouri: does rural versus urban residence matter? J Racial Ethn Health Disparities. 2016;3(2):233\u20139.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"4172_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2334-14-19","volume":"14","author":"SA Yimer","year":"2014","unstructured":"Yimer SA, Bjune GA, Holm-Hansen. C.Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia. BMC Infect Dis. 2014;14(1):19.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4172_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12905-018-0571-7","volume":"18","author":"J Kisiangani","year":"2018","unstructured":"Kisiangani J, Baliddawa J, Marinda P, et al. Determinants of breast cancer early detection for cues to expanded control and care: the lived experiences among women from Western Kenya. BMC Women\u2019s Health. 2018;18(1):81.","journal-title":"BMC Women\u2019s Health"},{"key":"4172_CR34","doi-asserted-by":"crossref","unstructured":"Kaufmann M, Kuhle J, Puhan MA et al. Factors associated with time from first-symptoms to diagnosis and treatment initiation of multiple sclerosis in Switzerland. Multiple Scler J - Experimental Translational Clin. 2018;4(4).","DOI":"10.1177\/2055217318814562"},{"issue":"680","key":"4172_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3399\/bjgp19X701729","volume":"69","author":"A Eccles","year":"2019","unstructured":"Eccles A. Debate and analysis delayed diagnosis of multiple sclerosis in males: May account for and dispel common Understandings of diferent MS types. Br J Gen Pract. 2019;69(680):148\u20139.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"4172_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2023.07.001","volume":"42","author":"M Kaisey","year":"2024","unstructured":"Kaisey M, Solomon AS. Multiple sclerosis diagnostic delay and misdiagnosis. Neurol Clin. 2024;42(1):1\u201313.","journal-title":"Neurol Clin"},{"key":"4172_CR37","first-page":"489","volume":"5","author":"N Levin","year":"2003","unstructured":"Levin N, Mor M, Ben-Hur T. Patterns of misdiagnosis of multiple sclerosis. Isr Med Assoc J. 2003;5:489\u201390.","journal-title":"Isr Med Assoc J"},{"key":"4172_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.msard.2013.11.004","volume":"3","author":"R Farber","year":"2014","unstructured":"Farber R, Hannigan C, Alcauskas M, Krieger S. Emergency department visits before the diagnosis of MS. Mult Scler Relat Disord. 2014;3:350\u20134.","journal-title":"Mult Scler Relat Disord"},{"key":"4172_CR39","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.msard.2021.102854","volume":"50","author":"S P\u00e9loquin","year":"2021","unstructured":"P\u00e9loquin S, et al. Challenges in multiple sclerosis care: results from an international mixed-methods study. Mult Scler Relat Disord. 2021;50:102854.","journal-title":"Mult Scler Relat Disord"},{"key":"4172_CR40","first-page":"ii3","volume":"71","author":"J Palace","year":"2001","unstructured":"Palace J. Making the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;71:ii3\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4172_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/CON.0000000000000323","volume":"22","author":"MA Willis","year":"2016","unstructured":"Willis MA, Fox RJ. Progressive multiple sclerosis. Continuum. 2016;22:785\u201398.","journal-title":"Continuum"},{"key":"4172_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1177\/13524585231197076","volume":"29","author":"T Uher","year":"2023","unstructured":"Uher T, Adzima A, Srpova B, Noskova L, Mar\u00e9chal B, Maceski AM, Krasensky J, Stastna D, Andelova M, Novotna K, Vodehnalova K, Mot\u00fdl J, Friedova L, Lindner J, Ravano V, Burgetova A, Dusek P, Fialova L, Havrdova E, Horakova D, Kober T, Kuhle J, Vaneckova M. Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Multiple Scler J. 2023;29:1437\u201351.","journal-title":"Multiple Scler J"},{"key":"4172_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1212\/WNL.0b013e3182535cf6","volume":"78","author":"DS Goodin","year":"2012","unstructured":"Goodin DS, Reder AT, Ebers GC, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFN\u03b2-1b trial. Neurology. 2012;78:1315\u201322.","journal-title":"Neurology"},{"key":"4172_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1212\/WNL.0000000000000541","volume":"83","author":"P O\u2019Connor","year":"2014","unstructured":"O\u2019Connor P, Goodman A, Kappos L, et al. Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS study. Neurology. 2014;83:78\u201386.","journal-title":"Neurology"},{"issue":"1","key":"4172_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","volume":"77","author":"K Bjornevik","year":"2020","unstructured":"Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, et al. Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol. 2020;77(1):58\u201364.","journal-title":"JAMA Neurol"},{"issue":"4","key":"4172_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ana.24769","volume":"80","author":"M Cortese","year":"2016","unstructured":"Cortese M, Riise T, Bjornevik K, Bhan A, Farbu E, Grytten N, et al. Preclinical disease activity in multiple sclerosis: a prospective study of cognitive performance prior to first symptom. Ann Neurol. 2016;80(4):616\u201324.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04172-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:25:24Z","timestamp":1757481924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04172-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4172"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04172-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved from the Institutional Ethics Committee of the Faculty of Medicine, Kafrelsheikh University (MKSU 50-7-4) according to the ethical criteria of the Declaration of Helsinki. A Written informed consent was obtained from all participants, as well as from the parents or legal guardians of those under the age of 16, after explaining the study\u2019s details, benefits, and potential risks.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}